Search Results

The researchers conducted a systematic review of 67 studies to compare the effectiveness of watchful waiting versus radical prostatectomy, along with several other treatments. The review is one of the first studies to look at very long-term results.

Today at age 56, Atkinson is fighting another battle—this time a case of aggressive prostate cancer. Thanks to treatment at the VA Portland Health Care System, his condition has improved dramatically in recent months through precision oncology—the molecular profiling of tumors to identify targetable alterations that can be treated therapeutically. Most recently, his PSA level had plummeted to 0.2, after a high of 115 in December.

Conversely, the researchers concluded that men with prostate cancer and PTSD may have been at lower risk of death from non-suicidal causes due to favorable physical health resulting from greater health care use and early diagnosis of localized—or low-risk—cancer.

Across the U.S., Black men are disproportionally diagnosed with prostate cancer and are more likely to die from the disease than their white counterparts.

VA teamed up with the Prostate Cancer Foundation (PCF) to encourage men (and their families) to better understand prostate cancer risk and taking proactive measures to protect their health.

Dr. Donald Gleason, who served in the U.S. Army Medical Corps, devised the scoring system in the 1960s while working at the Minneapolis VA Health Care System.

VA researchers will be testing the prostate cancer drug degarelix for treating nearly 200 COVID-19 patients at VA medical centers.

A new study funded by the National Institutes of Health and the Department of Defense found similar survival rates among black and white patients with prostate cancer receiving care at VA.

Hear the latest on treating prostate cancer. Check out a Feb. 24 lecture, online or in person at VA headquarters, on precision oncology for Veterans.

A partnership between VA and the Prostate Cancer Foundation is speeding the development of treatments and cures for Veterans with aggressive—or metastatic—prostate cancer through precision oncology.

Dr. Ted Skolarus is a urologic oncologist—a physician who treats cancer of the urinary tract and male reproductive system. He is also an investigator at the VA Ann Arbor Health Care System in Michigan. His research is focused on survivorship care for men who have undergone treatment for prostate cancer.

Dr. Stacy Loeb decided to help treat Veterans with prostate cancer when her grandfather was diagnosed with the disease. Her research is helping to determine the best treatment options.